碧桂園(02007.HK)附屬匯入6.2億人幣 提早完成境內債券回售資金支付
碧桂園(02007.HK)公佈,公司全資附屬碧桂園地產於2019年4月2日公開發行公司債券(第一期),本金總額爲5.9億人民幣(下同),票面利率5.03%,發行期限爲5年。公司已用自有資金於昨日(14日)提前將回售資金本息共近6.2億元全額匯入中登公司結算備付金專用賬戶。至此,碧桂園地產於今年境內到期/回售公司債項均已足額支付完畢。
公司指,目前現金流穩定,提前償還或按時全額償還到期/回售公司債本息是公司恪守的經營底線,未來公司也將持續保持穩健經營,繼續維護全體股東及投資者的權益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.